Guardant Health to Participate in the William Blair 2020 Growth Stock Conference

Ads

You May Also Like

ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA

This announcement contains inside information 10 August 2016 14:35 ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA ...

Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study

Proof of concept study of sequential ONCOS-102 then pembrolizumab treatment in patients with advanced ...